Insights

Market Positioning Granules Pharmaceuticals operates in the competitive pharmaceutical manufacturing sector with mid-sized revenue, positioning it as an attractive target for suppliers seeking to expand their presence within the United States' pharmaceutical supply chain.

Growth Potential With a revenue range between 100 million and 250 million and a team of up to 500 employees, the company presents opportunities for partnerships in expanding product lines or enhancing manufacturing capabilities.

Technology Adoption Utilizing advanced tech stacks like Google Cloud, Nginx, and PHP suggests a company open to adopting innovative digital solutions, ideal for vendors offering digital transformation or security services.

Industry Collaboration Given its scale and sector, Granules Pharmaceuticals may benefit from collaborations related to supply chain efficiency, compliance solutions, and manufacturing process optimization tailored for pharmaceutical companies.

Competitive Landscape Positioned among similar mid-sized pharma companies, there are opportunities for targeted value propositions focused on cost efficiency, quality assurance, and innovative R&D collaborations to differentiate from larger competitors.

Granules Pharmaceuticals, Inc. Tech Stack

Granules Pharmaceuticals, Inc. uses 8 technology products and services including Sucuri, Google Cloud, PHP, and more. Explore Granules Pharmaceuticals, Inc.'s tech stack below.

  • Sucuri
    Content Delivery Network
  • Google Cloud
    Infrastructure As A Service
  • PHP
    Programming Languages
  • Lua
    Programming Languages
  • HSTS
    Security
  • X-XSS-Protection
    Security
  • Nginx
    Web Servers
  • Apache HTTP Server
    Web Servers

Media & News

Granules Pharmaceuticals, Inc.'s Email Address Formats

Granules Pharmaceuticals, Inc. uses at least 1 format(s):
Granules Pharmaceuticals, Inc. Email FormatsExamplePercentage
First.Last@granulespharma.comJohn.Doe@granulespharma.com
98%
Last.First@granulespharma.comDoe.John@granulespharma.com
2%

Frequently Asked Questions

Where is Granules Pharmaceuticals, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Granules Pharmaceuticals, Inc.'s main headquarters is located at 3701 Concorde Parkway Chantilly, Virginia 20151 United States. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Granules Pharmaceuticals, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Granules Pharmaceuticals, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Granules Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
As of March 2026, Granules Pharmaceuticals, Inc. has approximately 485 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Commercial Officer (cco): D. R.Chief Financial Officer: K. M.Vice President – Portfolio, Bd & Commercial Operations: S. R. M.. Explore Granules Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does Granules Pharmaceuticals, Inc. belong to?

Minus sign iconPlus sign icon
Granules Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Granules Pharmaceuticals, Inc. use?

Minus sign iconPlus sign icon
Granules Pharmaceuticals, Inc.'s tech stack includes SucuriGoogle CloudPHPLuaHSTSX-XSS-ProtectionNginxApache HTTP Server.

What is Granules Pharmaceuticals, Inc.'s email format?

Minus sign iconPlus sign icon
Granules Pharmaceuticals, Inc.'s email format typically follows the pattern of First.Last@granulespharma.com. Find more Granules Pharmaceuticals, Inc. email formats with LeadIQ.

When was Granules Pharmaceuticals, Inc. founded?

Minus sign iconPlus sign icon
Granules Pharmaceuticals, Inc. was founded in 2014.

Granules Pharmaceuticals, Inc.

Pharmaceutical ManufacturingVirginia, United States201-500 Employees

Granules Pharmaceuticals, Inc. is a pharmaceuticals company based out of 3701 CONCORDE PKY, Chantilly, Virginia, United States.

Section iconCompany Overview

Headquarters
3701 Concorde Parkway Chantilly, Virginia 20151 United States
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2014
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $100M$250M

    Granules Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M$250M

    Granules Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.